Navigation Links
Global Med Technologies(R) Signs Agreement With California's Century Old Riverside County Regional Medical Center

Siemens and Wyndgate Partner to Provide Solution to Teaching Hospital

Serving Fourth Largest Population Center

DENVER, June 10 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. (OTC Bulletin Board: GLOB), an international e-Health, medical information technology company, today announced that its Wyndgate Technologies(R) division has signed an agreement to license its SafeTrace Tx(R) transfusion management software to Riverside County Regional Medical Center (RCRMC) of Moreno Valley, California, an institution serving the fourth largest population center. Wyndgate and Siemens worked in close collaboration to provide an interfacing software system for RCRMC between their respective transfusion management system and Laboratory Information System (LIS). Terms of the agreement were not disclosed.


SafeTrace Tx*, with its patented "Patient-At-A-Glance Bar", is designed to meet the specific needs of large scale transfusion services such as those provided by Riverside County Regional Medical Center. The blood management software system is designed to raise the standard of care for patients, improve safety, reduce waste and increase efficiency. SafeTrace Tx provides comprehensive tracking of orders, specimens, blood products, derivatives, and accessories with a complete testing and transfusion history in one consolidated record. These complex features will assist RCRMC in meeting the diverse needs of their large operation and will interface well with their award-winning laboratory information system, Siemens NOVIUS(R) Lab.

Wm. Scott Dustin, Vice President of Sales and Marketing at Wyndgate Technologies, commented, "Riverside County Regional Medical Center recognized its need for a system designed to enhance patient safety and streamline processes. Our SafeTrace Tx product is a recognized leader among transfusion management systems and we are pleased that it will be supporting the medical center's staff as they continue to provide quality, advanced healthcare to patients in their community." Mr. Dustin continued, "It is also a pleasure to be partnering with Siemens. We have been very pleased with the collaboration and the benefits it has delivered to our mutual customers. We look forward to continued success with Siemens at additional customer facilities."

About Riverside County Regional Medical Center

Riverside County Regional Medical Center is an award-winning teaching hospital offering programs for health professionals from schools including renowned Loma Linda University Medical School. RCRMC has served as Riverside County's primary trauma center and central facility for over 100 years. The new Medical Center, opened in 1998, is a 520,000 square foot state-of-the-art tertiary care and level II adult and pediatric facility, licensed for a total of 439 beds.

About Global Med Technologies, Inc.

Global Med Technologies(R), Inc. is an international e-Health medical information technology company providing information management software products and services to the healthcare industry. Its Wyndgate Technologies(R) division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Each year, Wyndgate's products and services manage more than eight million blood components, representing over 27% of the U.S. blood supply. Wyndgate's products are also being used in Canada, Africa, and the Caribbean. Wyndgate's software provides Vein-to-Vein(R) tracking from donor collection to patient transfusion through its Donor Doc(TM) interactive donor health history questionnaire, ElDorado(TM) Donor(TM) and SafeTrace(R) donor management systems, to its SafeTrace Tx(R) advanced transfusion management system. Global Med's PeopleMed(R), Inc. subsidiary provides custom software validation, consulting and compliance solutions to hospitals and blood centers. PeopleMed's in-depth knowledge of Wyndgate's products and the blood banking industry results in cost-effective validation services, which leads to more efficient software implementations and upgrades for our customers.

For more information about Global Med's products and services, please call 800-WYNDGATE or visit, and

*Patent No. 7363167

This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release.

SOURCE Global Med Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Health Experts Call on Global Leaders to Ensure Access to Life-Saving Pneumococcal Vaccines
2. Wyeth to Present at the Goldman Sachs Annual Global Healthcare Conference
3. World Medical Tourism & Global Health Congress Connects Global Healthcare Providers with Global Insurance Companies
4. Impact of Rising Gas, Food Prices Felt Globally
5. Alexion to Present at the Goldman Sachs 29th Annual Global Healthcare Conference
6. MAP Pharmaceuticals to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference
7. NuVasive to Present at Goldman Sachs 29th Annual Global Healthcare Conference
8. Edwards Lifesciences to Present at the Goldman Sachs 29th Annual Global Healthcare Conference
9. Insurance Company Includes Global Network Option in Limited Benefit Plans
10. HealthSTAR Public Relations Joins GlobalCom PR-Network of International Agencies
11. Viacom to Receive Leadership Award for Business Excellence from The Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria for Its 25 Years of Work on HIV/AIDS Education and Advocacy
Post Your Comments:
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from reveals that behind ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. ... The attorneys chosen by their peers for this recognition are considered among the top ... Shareholders received special honors as members of this year’s Legal Elite Hall of Fame: ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Calif. , June 23, 2016 Any dentist ... many challenges of the current process. Many of them do ... of the technical difficulties and high laboratory costs involved. And ... to offer it at such a high cost that the ... it. Dr. Parsa Zadeh , founder of ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: